TriangleHEALTH PROFESSIONAL · SOURCE READING
Mammalian target of rapamycin (mTOR) inhibitors
Source: Renal Cell Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 13, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Stage IV and Recurrent Renal Cell Cancer / Antiangiogenic and Other Targeted Therapy
Continue within this section
Preserved source evidence · Not medical advice